We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio The FDA has set a new target action date ...
Please provide your email address to receive an email when new articles are posted on . The FDA has extended the prescription drug user fee act target action date for the new drug application for ...
MedPage Today on MSN
Nasal Spray Epinephrine Increasingly Used in the Office
Intranasal epinephrine was administered within 1 minute of identifying the reaction or when the patient returned to the ...
ARS Pharma to showcase a late-breaking oral presentation and six poster presentations highlighting real world impact of neffy® (epinephrine nasal spray) Oral presentation reports about 9 out of every ...
Shares of ARS Pharmaceuticals (NASDAQ:SPRY) rose 13% Friday after the company announced it had received FDA approval for its epinephrine nasal spray for the treatment of severe allergic reactions. ARS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback